Latest Senior Health News


FDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not Younger

FDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not YoungerFRIDAY, Sept. 17, 2021 (HealthDay News) -- An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for severe illness.According to The New York Times, that vote came after a near unanimous decision (16 to 2) by the same independent panel of experts that said no to booster shots for Americans younger than 65. The recommendation against booster shots for younger adults is a setback for the Biden administration, which earlier in the summer had pledged a rollout of boosters to the general population by this coming Monday, Sept. 20.FDA advisory committee decisions are not binding on the agency, but it usually does follow its...

Common Eye Conditions Tied to Higher Risk for Dementia

17 September 2021
Common Eye Conditions Tied to Higher Risk for DementiaFRIDAY, Sept. 17, 2021 (HealthDay News) -- Diseases that can rob you of vision as you age also appear to be tied to an increased risk for dementia, a new study finds. Specifically, age-related macular degeneration, cataracts and diabetes-related eye disease were linked with a higher likelihood of dementia, researchers in China said. However, one other common eye ailment, glaucoma, was not linked to dementia risk.The new study can't prove that vision problems cause dementia, only that the two appear to be associated, the researchers stressed. Risks for dementia rose even higher if other chronic ills were added in."Newly developed hypertension, diabetes, stroke, heart disease and depression mediated [affected] the association between cataract/ diabetes-related eye disease and dementia,"...

Could Cholesterol Help Drive Alzheimer's Disease?

17 September 2021
Could Cholesterol Help Drive Alzheimer`s Disease?FRIDAY, Sept. 17, 2021 (HealthDay News) -- Cholesterol made in the brain may spur development of Alzheimer's disease, a new study suggests.Cholesterol made by cells called astrocytes is needed for controlling production of amyloid beta, a sticky protein that builds up in the brain and accumulates into the plaques that are the tell-tale sign of Alzheimer's.Researchers say these new findings may offer insight into how and why plaques form and may help explain why genes tied with cholesterol have been linked to increased Alzheimer's risk."This study helps us to understand why genes linked to cholesterol are so important to the development of Alzheimer's disease," said study co-author Dr. Heather Ferris, an assistant professor at the University of Virginia School of Medicine. "Our data...

Why Logging May Be the Most Dangerous Profession

17 September 2021
Why Logging May Be the Most Dangerous ProfessionFRIDAY, Sept. 17, 2021 (HealthDay News) -- Logging and landscaping are the most dangerous jobs in America, a new study finds.The risk of death for loggers is more than 30 times higher than for all U.S. workers. Tree care workers also encounter hazards at rates far higher than a typical worker."This was the first research to look at commercial logging and landscaping services together," said Judd Michael, a professor of agricultural safety and health at Penn State College of Agricultural Sciences. "It was a unique and more accurate way to assess fatalities," he said in a university news release. "The commonality, of course, is that workers in both fields fell trees. They do it using very different methods, but either way, it is extremely hazardous work."Logging in Appalachia and other...

Trial Into Antioxidant for Parkinson's Disease Yields Disappointing Results

17 September 2021
Trial Into Antioxidant for Parkinson`s Disease Yields Disappointing ResultsFRIDAY, Sept. 17, 2021 (HealthDay News) – Researchers hoped to show that the natural antioxidant urate could delay Parkinson's disease progression, but a study completed at Massachusetts General Hospital dashed those expectations.The trial enrolled nearly 300 individuals recently diagnosed with early Parkinson's disease, which affects the body's motor system. Symptoms such as tremors, stiff limbs and balance problems progress gradually, and there is no known cure.The research team found no significant difference in the rate of disease progression for those given the metabolite inosine for two years compared to the placebo group. Inosine raises levels of urate in the brain and blood. It has appeared neuroprotective in preclinical models. The inosine did not prove beneficial, and...

Copyright © 2018 HealthDay. All rights reserved.